Lumina Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Lumina Fund Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,000	Closed	-$695K	–	49
2023 Q3	$695K	Hold	2,000	–	–	0.24%	32
2023 Q2	$704K	Hold	2,000	–	–	0.3%	36
2023 Q1	$630K	Hold	2,000	–	–	0.3%	37
2022 Q4	$578K	Hold	2,000	–	–	0.22%	35
2022 Q3	$579K	Hold	2,000	–	–	0.22%	28
2022 Q2	$564K	Hold	2,000	–	–	0.21%	31
2022 Q1	$522K	Sell	2,000 -2,000	-50%	-$475K	0.17%	40
2021 Q4	$878K	Hold	4,000	–	–	0.27%	21
2021 Q3	$726K	Buy	4,000 +3,600	+900%	+$703K	0.26%	26
2021 Q2	$81K	Buy	+400	New	+$83.7K	0.04%	38

Other funds holding VRTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lumina Fund Management's VRTX Position: Q4 2023 in Review

Lumina Fund Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2023, closing a stake of 2,000 shares — an estimated $695K sold.

Lumina Fund Management first reported a position in VRTX in Q2 2021 and held it in 10 quarters. The position peaked at $878K in Q4 2021. 1,438 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

Lumina Fund Management reported no remaining Vertex Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Lumina Fund Management sold 2,000 Vertex Pharmaceuticals shares in Q4 2023, an estimated $695K.
Lumina Fund Management first reported a position in Vertex Pharmaceuticals in Q2 2021 and held it in 10 quarters.
Lumina Fund Management's Vertex Pharmaceuticals position peaked at $878K in Q4 2021.
1,438 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on Lumina Fund Management's 13F filing for Q4 2023, filed 2 Feb 2024.